Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 7 studies | 38% ± 21% | |
GABAergic neuron | 6 studies | 34% ± 21% | |
oligodendrocyte precursor cell | 4 studies | 24% ± 7% | |
interneuron | 4 studies | 35% ± 22% | |
neuron | 3 studies | 27% ± 5% | |
endothelial cell | 3 studies | 27% ± 7% | |
basal cell | 3 studies | 21% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 28% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5594.11 | 2632 / 2642 | 99% | 26.11 | 697 / 705 |
thymus | 88% | 756.49 | 573 / 653 | 86% | 7.14 | 519 / 605 |
prostate | 82% | 888.76 | 202 / 245 | 89% | 5.61 | 445 / 502 |
esophagus | 38% | 354.10 | 545 / 1445 | 87% | 7.06 | 159 / 183 |
lung | 43% | 281.38 | 247 / 578 | 79% | 5.11 | 912 / 1155 |
breast | 34% | 232.45 | 154 / 459 | 82% | 7.42 | 912 / 1118 |
stomach | 29% | 171.31 | 103 / 359 | 81% | 4.97 | 232 / 286 |
pancreas | 21% | 117.27 | 68 / 328 | 88% | 6.01 | 156 / 178 |
bladder | 24% | 126.95 | 5 / 21 | 72% | 4.66 | 365 / 504 |
intestine | 10% | 65.41 | 98 / 966 | 78% | 4.39 | 412 / 527 |
adrenal gland | 9% | 62.06 | 22 / 258 | 80% | 13.42 | 183 / 230 |
tonsil | 0% | 0 | 0 / 0 | 82% | 5.09 | 37 / 45 |
uterus | 3% | 24.31 | 5 / 170 | 74% | 5.65 | 339 / 459 |
ovary | 0% | 0 | 0 / 180 | 75% | 5.75 | 322 / 430 |
kidney | 28% | 250.12 | 25 / 89 | 42% | 2.99 | 380 / 901 |
skin | 40% | 241.71 | 730 / 1809 | 9% | 0.35 | 42 / 472 |
liver | 0% | 0 | 0 / 226 | 24% | 1.31 | 99 / 406 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.56 | 6 / 29 |
eye | 0% | 0 | 0 / 0 | 11% | 0.50 | 9 / 80 |
blood vessel | 6% | 37.13 | 86 / 1335 | 0% | 0 | 0 / 0 |
heart | 3% | 13.85 | 23 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 2% | 14.31 | 21 / 929 | 0% | 0 | 0 / 0 |
adipose | 0% | 0.35 | 1 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006468 | Biological process | protein phosphorylation |
GO_0005575 | Cellular component | cellular_component |
GO_0000139 | Cellular component | Golgi membrane |
GO_0030424 | Cellular component | axon |
GO_0030425 | Cellular component | dendrite |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0003674 | Molecular function | molecular_function |
GO_0004672 | Molecular function | protein kinase activity |
Gene name | LMTK3 |
Protein name | Lemur tyrosine kinase 3 Serine/threonine-protein kinase LMTK3 (EC 2.7.11.1) (Lemur tyrosine kinase 3) |
Synonyms | KIAA1883 TYKLM3 |
Description | FUNCTION: Protein kinase which phosphorylates ESR1 (in vitro) and protects it against proteasomal degradation. May also regulate ESR1 levels indirectly via a PKC-AKT-FOXO3 pathway where it decreases the activity of PKC and the phosphorylation of AKT, thereby increasing binding of transcriptional activator FOXO3 to the ESR1 promoter and increasing ESR1 transcription . Involved in endocytic trafficking of N-methyl-D-aspartate receptors (NMDAR) in neurons (By similarity). . |
Accessions | ENST00000673139.1 A0A3B3ITQ7 A0A3B3ISL5 Q96Q04 A0A3B3IRV9 ENST00000648216.1 A0A5F9ZHT0 ENST00000598924.1 ENST00000672160.1 ENST00000650440.1 ENST00000600059.6 A0A5F9ZH67 ENST00000647709.2 |